23/05/2024  16:43:03 Chg. -1.000 Volume Bid16:55:57 Demandez à16:55:57 Capitalisation boursière Dividende Y. Rapport P/E
478.000EUR -0.21% 6
Chiffrre d'affaires: 2,859.400
477.700Bid taille: 31 478.900Ask la taille: 31 39.56 Mrd.EUR - -

Description de l'entreprise

IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 7,000 people and offers products to customers in more than 175 countries.
 

Conseil d'administration & Conseil de surveillance

PDG
Jay Mazelsky
Conseil d'administration
Brian P. McKeon, Irene Chang Britt, Michael Lane, James F. Polewaczyk, Martin Smith, Sharon E. Underberg, Michael P. Johnson, Kerry Bennett, Mike Erickson, George J. Fennell, Ken Grady, John Hart, Dan Janson, Michael Schreck, Murthy Yerramilli
Conseil de surveillance
Lawrence D. Kingsley, Bruce L. Claflin, Daniel M. Junius, Dr. Asha S. Collins, Dr. Sophie V. Vandebroek, Dr. Stuart M. Essig, Jay Mazelsky, Jonathan W. Ayers, M. Anne Szostak, Sam Samad, Irene Chang Britt
 

Données de l'entreprise

Nom: IDEXX Laboratories Inc.
Adresse: One IDEXX Drive,Westbrook, Maine 04092, USA
Téléphone: +1-207-556-0300
Fax: +1-207-556-4346
Courriel: -
Internet: www.idexx.com
Industrie: Biotechnology
Secteur: Biotechnology
Sous-secteur: Biotechnology
Fin de l'exercice financier: 31/12
Flotte libre: 57.24%
IPO date: 21/06/1991

Relations avec les investisseurs

Nom: John Ravis
Téléphone IR: +1-207-556-8155
IR-Fax: +1-207-556-4427
E-mail IR: investorrelations@idexx.com

Calendrier de l'entreprise

CW 33 | 15/08/2024 General Shareholder Meeting
 

Principaux actionnaires

Autres
 
57.24%
Blackrock Inc.
 
10.42%
Vanguard Group Inc
 
9.94%
State Street Corporation
 
4.54%
Alliancebernstein L.P.
 
4.33%
Alliancebernstein L.P.
 
3.57%
BAMCO Inc.
 
2.86%
Geode Capital Management, LLC
 
2.43%
Franklin Resources, Inc.
 
1.74%
Autres
 
2.93%